Medical Weight Loss for Midwest City, Oklahoma Residents

Midwest City, Oklahoma residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Midwest City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Oklahoma: there is no local Midwest City office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why Midwest City Residents Choose New Hope Weight Loss

We are built for people who would rather not deal with insurance at all. New Hope is cash-pay friendly, so there are no prior authorizations, no denials, and no waiting on a carrier to decide what you are allowed to try. Patients in Midwest City pay a flat physician fee of $119 and a clear monthly medication price, and we accept HSA, FSA, Klarna, and Affirm so the cost can fit your budget without a fight.

Midwest City is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Midwest City patients at home.

Think of our Costa Mesa clinic as your weight-loss provider even though you live in Midwest City, because telehealth delivers the same physician-led program to Oklahoma without asking you to leave home. We care for patients throughout Midwest City and the eastern Oklahoma City metro area. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Midwest City, even on warm Oklahoma afternoons.

By handling visits through telehealth, we serve every neighborhood in Midwest City, from Midwest City and the eastern Oklahoma City metro area, without asking anyone to travel. Getting started in Midwest City is simple: a Oklahoma licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. Wherever you are in Oklahoma, New Hope Weight Loss delivers physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic, with no in-person appointment required.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Midwest City.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Midwest City

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your Midwest City home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, Midwest City

Where is the closest New Hope Weight Loss to Midwest City?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Midwest City, Oklahoma patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Midwest City?

It is not. We run a complete telehealth model, so people in Midwest City handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Midwest City using cold-pack insulation that keeps it stable until it reaches you.

What should a Midwest City patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Midwest City patients are not charged any extra distance fee.

What areas of Midwest City do you serve?

We serve patients from across Midwest City by telehealth, including Midwest City and the eastern Oklahoma City metro area.

How does compounded medication compare on cost for Midwest City patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Midwest City patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Midwest City Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Midwest City, Oklahoma by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.